Literature DB >> 7701022

Bromocriptine and psychosis: a literature review.

A Boyd1.   

Abstract

Bromocriptine is an ergot-derived dopamine agonist. Its current uses include the treatment of Parkinson's disease, postpartum ablaction, prolactinomas, acromegaly, and amenorrhea and galactorrhea secondary to neuroleptic use. It is often reported to produce psychiatric side effects such as confusion, hallucinations, and delusions. The literature is reviewed and supports a strong anecdotal relationship between bromocriptine use and psychosis.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7701022     DOI： 10.1007/bf02238717

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN： 0033-2720


  39 in total

Review 1.  Drug therapy: Bromocriptine.

Authors:  D Parkes
Journal:  N Engl J Med       Date:  1979-10-18       Impact factor: 91.245

2.  Clozapine treatment of drug-induced psychotic symptoms in late stages of Parkinson's disease.

Authors:  K Ostergaard; E Dupont
Journal:  Acta Neurol Scand       Date:  1988-10       Impact factor: 3.209

3.  Bromocriptine induced psychosis in acromegaly.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-01

4.  Psychotic reactions during treatment of pituitary tumours with dopamine agonists.

Authors:  T H Turner; J C Cookson; J A Wass; P L Drury; P A Price; G M Besser
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-27

5.  Bromocriptine-induced psychosis in acromegaly.

Authors:  C M Le Feuvre; A J Isaacs; O S Frank
Journal:  Br Med J (Clin Res Ed)       Date:  1982-11-06

6.  Bromocriptine-induced mania?

Authors:  N M Brook; I B Cookson
Journal:  Br Med J       Date:  1978-03-25

7.  Mental disorders from low-dose bromocriptine.

Authors:  K C Pearson
Journal:  N Engl J Med       Date:  1981-07-16       Impact factor: 91.245

8.  Treatment of drug-induced exogenous psychosis in parkinsonism with clozapine and fluperlapine.

Authors:  E Scholz; J Dichgans
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1985

9.  A randomised controlled study of bromocriptine versus levodopa in previously untreated Parkinsonian patients: a 3 year follow-up.

Authors:  J L Montastruc; O Rascol; A Rascol
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

10.  Hypersexuality--a complication of dopaminergic therapy in Parkinson's disease.

Authors:  H P Vogel; R Schiffter
Journal:  Pharmacopsychiatria       Date:  1983-07
View more
  14 in total

1.  Is cabergoline a better drug to inhibit lactation in patients with psychotic symptoms?

Authors:  Inmaculada Baeza Pertegaz; José Manuel Goikolea Alberdi; Eduard Parellada Rodón
Journal:  J Psychiatry Neurosci       Date:  2002-01       Impact factor: 6.186

Review 2.  Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?

Authors:  L Dépatie; S Lal
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

Review 3.  Cabergoline-induced manic episode: case report.

Authors:  Rabia Nazik Yüksel; Zeynep Elyas Kaya; Nesrin Dilbaz; Merve Cingi Yirün
Journal:  Ther Adv Psychopharmacol       Date:  2016-01-21

4.  Working memory span capacity improved by a D2 but not D1 receptor family agonist.

Authors:  Isadore S Tarantino; Richard F Sharp; Mark A Geyer; Jessica M Meves; Jared W Young
Journal:  Behav Brain Res       Date:  2011-01-11       Impact factor: 3.332

Review 5.  Cabergoline in acromegaly.

Authors:  Emmanuelle Kuhn; Philippe Chanson
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

6.  Dopamine Agonists and their risk to induce psychotic episodes in Parkinson's disease: a case-control study.

Authors:  Daniel Ecker; Alexander Unrath; Jan Kassubek; Michael Sabolek
Journal:  BMC Neurol       Date:  2009-06-10       Impact factor: 2.474

7.  Aripiprazole use combined with depot antipsychotic medication: two cases demonstrating its ability to reduce prolactin levels in an adolescent forensic hospital.

Authors:  Simon A Hill; Al Aditya Khan; Marion Wetherill
Journal:  Ther Adv Psychopharmacol       Date:  2011-06

8.  Treatment complexities of a young woman suffering psychosis and pituitary adenoma.

Authors:  Maxine Sigman; Kate Drury
Journal:  Case Rep Psychiatry       Date:  2011-11-02

9.  Psychiatric side effects of medications prescribed in internal medicine.

Authors:  Rodrigo Casagrande Tango
Journal:  Dialogues Clin Neurosci       Date:  2003-06       Impact factor: 5.986

10.  Endocrinological outcomes of pure endoscopic transsphenoidal surgery: a Croatian Referral Pituitary Center experience.

Authors:  Andreja Marić; Ivan Kruljac; Vatroslav Čerina; Hrvoje Ivan Pećina; Petra Šulentić; Milan Vrkljan
Journal:  Croat Med J       Date:  2012-06       Impact factor: 1.351
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.